Results 241 to 250 of about 34,514 (296)

Implantable cardioverter-defibrillators

Journal of Cardiothoracic and Vascular Anesthesia, 1999
Abstract In the quest to save lives, a greater number of ICDs are implanted each year. These ICDs with pacing capabilities offer a successful therapeutic intervention to a devastating problem. Patients who have these devices will appear in operating rooms around the country. Manage these patients like all other patients who have heart disease, before
S L, Pinski, G J, Fahy
openaire   +4 more sources

Implantable Cardioverter-Defibrillators

American Journal of Therapeutics, 2010
The automatic implantable cardioverter-defibrillator (AICD) is the most effective treatment for patients with life-threatening ventricular tachycardia or ventricular fibrillation. The American College of Cardiology/American Heart Association class I, IIa, and III indications for an AICD are discussed.
Jose L. Baez-Escudero, Miguel Valderrábano   +1 more
openaire   +3 more sources

Implantable cardioverter defibrillators

Proceedings of the IEEE, 1996
The electrical design challenges for implantable defibrillators are discussed based on the following criteria: device evolution, system architecture, therapy delivery, mid heart activity sensing circuits. The discussion includes the incidence of sudden cardiac death and the clinical requirements of device hardware.
Jay A. Warren, Robert D. Dreher, Ronald V. Jaworski, James J. Putzke, Renold J. Russie   +4 more
openaire   +3 more sources

The implantable cardioverter defibrillator

Hospital Medicine, 2002
The implantable cardioverter defibrillator is the optimal treatment for both primary and secondary prevention in patients with previous aborted sudden death and with life-threatening cardiac arrhythmias. This article will review the indications and the evidence supporting implantable cardioverter defibrillator use.
C A, Rinaldi, J S, Gill
openaire   +2 more sources

The implantable cardioverter defibrillator

The Lancet, 2001
Implantable cardioverter defibrillators (ICDs) have evolved from the treatment of last resort to the gold standard therapy for patients at high risk for ventricular tachyarrhythmias. High-risk patients include those who have survived life-threatening arrhythmias, and individuals with cardiac diseases who are at risk for such arrhythmias, but are ...
M, Glikson, P A, Friedman
openaire   +2 more sources

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

Emergency Medicine Clinics of North America, 1998
Implantable cardioverter defibrillators have proven to be an effective therapy for life-threatening ventricular arrhythmias. Given the ever-increasing number of patients who have these devices, increasing numbers of patients are likely to present to emergency departments with defibrillator-related problems. This article discusses normal device function,
C P, Shah, R K, Thakur, B, Xie, V K, Hoon   +3 more
openaire   +2 more sources

Implantable Cardioverter Defibrillator:

Journal of Cardiovascular Electrophysiology, 1993
Implantable Cardioverter Defibrillator. The Ventritex® Cadence® Model V‐100 Tiered Therapy Defibrillator is a third generation antitachyarrhythmia device currently completing clinical trials in the United States. The implantable pulse generator is capable of high energy detibrillation, low energy cardioversion, as well as antitachycardia and ...
E S, Fain, R A, Winkle
openaire   +2 more sources

Implantable Cardioverter–Defibrillators

New England Journal of Medicine, 2003
Most people do not survive out-of-hospital cardiac arrest, and those who do may have substantial long-term cognitive and motor impairment. ICDs may avert such events. This review discusses the mechanisms of ICDs, clinical studies of their effectiveness, and management issues.
openaire   +2 more sources